From: Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
 | Overall | Men | Women | |||
---|---|---|---|---|---|---|
Measure | Case/control (n) | Adjusted OR1(95% CI) | Case/control (n) | Adjusted OR1(95% CI) | Case/control (n) | Adjusted OR1(95% CI) |
C-Peptide | Â | Â | Â | Â | Â | Â |
Quartile 1 | 29/106 | 1.0 (Referent) | 14/40 | 1.0 (Referent) | 15/66 | 1.0 (Referent) |
Quartile 2 | 32/108 | 1.2 (0.6, 2.1) | 19/42 | 1.9 (0.7, 4.8) | 13/66 | 0.8 (0.3, 2.1) |
Quartile 3 | 40/101 | 1.4 (0.8, 2.6) | 24/40 | 2.6 (1.0, 6.9) | 16/61 | 1.0 (0.4, 2.4) |
Quartile 4 | 71/105 | 2.2 (1.2, 4.0) | 48/45 | 4.4 (1.7, 10.9) | 23/60 | 1.6 (0.7, 4.0) |
P trend | Â | 0.04 | Â | 0.006 | Â | 0.58 |
IGFBP-1 | Â | Â | Â | Â | Â | Â |
Quartile 1 | 51/106 | 1.0 (Referent) | 36/41 | 1.0 (Referent) | 15/65 | 1.0 (Referent) |
Quartile 2 | 52/103 | 0.9 (0.5, 1.6) | 35/49 | 0.7 (0.3, 1.5) | 17/54 | 1.2 (0.5, 3.0) |
Quartile 3 | 37/105 | 0.7 (0.4, 1.2) | 22/42 | 0.5 (0.2, 1.0) | 15/63 | 1.3 (0.5, 3.1) |
Quartile 4 | 29/105 | 0.6 (0.3, 1.1) | 10/35 | 0.3 (0.1, 0.7) | 19/70 | 1.4 (0.6, 3.4) |
P trend | Â | 0.13 | Â | 0.007 | Â | 0.47 |
Insulin | Â | Â | Â | Â | Â | Â |
Quartile 1 | 21/88 | 1.0 (Referent) | 14/37 | 1.0 (Referent) | 7/51 | 1.0 (Referent) |
Quartile 2 | 27/84 | 1.7 (0.8, 3.7) | 17/32 | 1.3 (0.5, 3.5) | 10/52 | 2.6 (0.7, 9.0) |
Quartile 3 | 40/81 | 2.6 (1.2, 5.5) | 29/31 | 3.1 (1.2, 7.9) | 11/50 | 2.4 (0.7, 8.6) |
Quartile 4 | 55/84 | 3.5 (1.7, 7.4) | 31/33 | 2.8 (1.1, 7.1) | 24/51 | 4.6 (1.5, 15.3) |
P trend | Â | 0.002 | Â | 0.02 | Â | 0.03 |